It was a major week for healthcare stocks, with 24 out of 60 companies reporting their results.
Pharmaceutical heavyweights like Pfizer (PFE), Viatris (VTRS), and Moderna (MRNA) posted broadly positive quarterly results throughout the week
The State Street Health Care Entering text into the input field will update the search result below Quick Insights The healthcare ETF remained flat during the week as broader markets plunged. Year to date, healthcare had gained more than 19%, versus 7% for the S&P 500. Of 24 companies reporting, 23 beat EPS estimates and 20 beat revenue estimates.
Year-over-year earnings grew at 21 firms, while revenue grew at 18. Pfizer and Viatris raised full-year guidance, while Moderna beat quarterly expectations and lifted its full-year growth outlook. Viatris missed revenue consensus, and Modernaâs planned cancer vaccine launch remains subject to regulatory approval